Tech Company Financing Transactions
Equinom Funding Round
Equinom, based in Indianapolis, secured $35 million in investment from Synthesis Capital, BayWa and Bunge.
Transaction Overview
Company Name
Announced On
12/12/2022
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Undisclosed
Investors
Synthesis Capital (Lead Investor) (Costa Yiannoulis)
Proceeds Purpose
Equinom will use this new capital to accelerate the commercialization of its plant-based protein ingredients which will be sold to food companies via established multinational ingredient suppliers. The capital will also fund investments in seed development and grain production of their ultra-high protein varieties of non-GMO soy and pea, along with the addition of key personnel and research and development into ongoing breeding programs for additional protein source crops including chickpea, fava, mung bean, and cowpea.
Company Information
Company Status
Private & Independent
Industry
FoodTech
Mailing Address
Undisclosed
Indianapolis, IN Undisclosed
USA
Indianapolis, IN Undisclosed
USA
Phone
Website
Email Address
Overview
Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients -- from the ground up.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gil Shalev
Chief Financial Officer
Tsipi Kagan
Chief Marketing Officer
Galit Feinreich
Chief Operating Officer
Oron Gar
Browse more venture capital transactions:
Prev: 12/12/2022: Taeillo venture capital transaction
Next: 12/12/2022: Commons Clinic venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs